Compare Stocks: NMTC, NYXH, DXR, and SRTS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXR Daxor	$10.27	$10.39	$8.56 ▼ $14.76	$59.98M	0.26	7,815 shs	6,792 shs
NMTC NeuroOne Medical Technologies	$1.62	$2.12	$1.42 ▼ $6.96	$14.76M	0.65	800,324 shs	81,096 shs
NYXH Nyxoah	$1.62	$1.57	$1.26 ▼ $6.87	$62.79M	1.63	521,906 shs	1.00 million shs
SRTS Sensus Healthcare	$3.19	$3.09	$2.66 ▼ $5.49	$52.51M	1.13	47,919 shs	16,499 shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXR Daxor	0.00%	+0.69%	+0.88%	+2.17%	-7.14%
NMTC NeuroOne Medical Technologies	0.00%	-8.47%	-0.61%	-53.18%	-65.94%
NYXH Nyxoah	0.00%	+1.25%	+10.20%	+16.55%	-72.68%
SRTS Sensus Healthcare	0.00%	-9.38%	+3.91%	+18.59%	-1.24%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXR Daxor	$10.27	$10.39	$8.56 ▼ $14.76	$59.98M	0.26	7,815 shs	6,792 shs
NMTC NeuroOne Medical Technologies	$1.62	$2.12	$1.42 ▼ $6.96	$14.76M	0.65	800,324 shs	81,096 shs
NYXH Nyxoah	$1.62	$1.57	$1.26 ▼ $6.87	$62.79M	1.63	521,906 shs	1.00 million shs
SRTS Sensus Healthcare	$3.19	$3.09	$2.66 ▼ $5.49	$52.51M	1.13	47,919 shs	16,499 shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXR Daxor	0.00%	+0.69%	+0.88%	+2.17%	-7.14%
NMTC NeuroOne Medical Technologies	0.00%	-8.47%	-0.61%	-53.18%	-65.94%
NYXH Nyxoah	0.00%	+1.25%	+10.20%	+16.55%	-72.68%
SRTS Sensus Healthcare	0.00%	-9.38%	+3.91%	+18.59%	-1.24%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DXR Daxor	2.50	Moderate Buy	N/A	N/A
NMTC NeuroOne Medical Technologies	2.40	Hold	$7.33	352.67% Upside
NYXH Nyxoah	2.25	Hold	$4.26	163.09% Upside
SRTS Sensus Healthcare	2.50	Moderate Buy	$5.83	82.86% Upside

Current Analyst Ratings Breakdown

Latest NMTC, NYXH, DXR, and SRTS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2026	NMTC NeuroOne Medical Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/19/2026	NYXH Nyxoah	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
8/18/2026	SRTS Sensus Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (D-)
8/17/2026	SRTS Sensus Healthcare	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/17/2026	NYXH Nyxoah	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$6.00
8/14/2026	SRTS Sensus Healthcare	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$4.50 ➝ $4.00
8/14/2026	NMTC NeuroOne Medical Technologies	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$13.00 ➝ $5.00
8/6/2026	NYXH Nyxoah	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$2.31
8/6/2026	NYXH Nyxoah	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$7.00 ➝ $6.00
8/6/2026	NYXH Nyxoah	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$4.00
7/28/2026	NMTC NeuroOne Medical Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 9/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DXR Daxor	N/A	N/A	N/A	N/A	N/A	N/A
NMTC NeuroOne Medical Technologies	$12.10M	1.22	N/A	N/A	$0.85 per share	1.91
NYXH Nyxoah	$11.33M	5.54	N/A	N/A	$1.43 per share	1.13
SRTS Sensus Healthcare	$27.48M	1.91	N/A	N/A	$2.93 per share	1.09

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DXR Daxor	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NMTC NeuroOne Medical Technologies	-$3.61M	-$0.95	N/A	N/A	N/A	-71.50%	-128.12%	-86.34%	N/A
NYXH Nyxoah	-$101.92M	-$2.52	N/A	N/A	N/A	-443.16%	-178.90%	-81.83%	11/5/2026 (Estimated)
SRTS Sensus Healthcare	-$7.72M	-$0.94	N/A	N/A	N/A	-88.45%	-21.57%	-19.20%	11/5/2026 (Estimated)

Latest NMTC, NYXH, DXR, and SRTS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q3 2026	NMTC NeuroOne Medical Technologies	-$0.21	-$0.28	-$0.07	-$0.28	$2.17 million	$1.97 million
8/13/2026	Q2 2026	SRTS Sensus Healthcare	-$0.1250	-$0.53	-$0.4050	-$0.53	$4.60 million	$2.29 million
8/6/2026	Q2 2026	NYXH Nyxoah	-$0.47	-$0.67	-$0.20	-$0.66	$8.64 million	$8.76 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DXR Daxor	N/A	N/A	N/A	N/A	N/A
NMTC NeuroOne Medical Technologies	N/A	N/A	N/A	N/A	N/A
NYXH Nyxoah	N/A	N/A	N/A	N/A	N/A
SRTS Sensus Healthcare	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DXR Daxor	N/A	N/A	N/A
NMTC NeuroOne Medical Technologies	N/A	2.84	1.71
NYXH Nyxoah	0.44	2.38	2.31
SRTS Sensus Healthcare	N/A	8.71	4.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DXR Daxor	1.34%
NMTC NeuroOne Medical Technologies	16.07%
NYXH Nyxoah	N/A
SRTS Sensus Healthcare	25.30%

Insider Ownership

Company	Insider Ownership
DXR Daxor	51.50%
NMTC NeuroOne Medical Technologies	11.80%
NYXH Nyxoah	N/A
SRTS Sensus Healthcare	10.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DXR Daxor	37	5.84 million	2.83 million	Not Optionable
NMTC NeuroOne Medical Technologies	20	9.11 million	8.03 million	Optionable
NYXH Nyxoah	110	38.76 million	N/A	Not Optionable
SRTS Sensus Healthcare	40	16.46 million	14.78 million	Optionable

NMTC, NYXH, DXR, and SRTS Headlines

Recent News About These Companies

Sensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Purchases 27,304 Shares of Stock

September 1, 2026 | insidertrades.com

Sensus Healthcare Inc

August 31, 2026 | money.usnews.com

Eric Sachetta Acquires 27,304 Shares of Sensus Healthcare (NASDAQ:SRTS) Stock

August 31, 2026 | marketbeat.com

Sensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Purchases 37,537 Shares of Stock

August 31, 2026 | marketbeat.com

Insider Buying: Sensus Healthcare (NASDAQ:SRTS) Director Buys $31,939.32 in Stock

August 29, 2026 | insidertrades.com

Insider Buying: Sensus Healthcare (NASDAQ:SRTS) Director Buys 9,708 Shares

August 28, 2026 | marketbeat.com

Sensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Acquires 10,925 Shares of Stock

August 28, 2026 | marketbeat.com

Sensus Healthcare (NASDAQ:SRTS) Director Eric Sachetta Acquires 34,697 Shares

August 26, 2026 | insidertrades.com

Insider Buying: Sensus Healthcare (NASDAQ:SRTS) Director Acquires $112,765.25 in Stock

August 25, 2026 | marketbeat.com

Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Recommendation of "Moderate Buy" from Brokerages

August 24, 2026 | marketbeat.com

Sensus (SRTS) Q2 2026 Earnings Call Transcript

August 21, 2026 | finance.yahoo.com

Sensus outlines shift to $250,000 average selling price as it targets a stronger second half

August 14, 2026 | seekingalpha.com

Sensus Healthcare Q2 Earnings Call Highlights

August 13, 2026 | marketbeat.com

Sensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call Transcript

August 13, 2026 | seekingalpha.com

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.41 EPS

August 13, 2026 | marketbeat.com

Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights

August 13, 2026 | businesswire.com

Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026

July 30, 2026 | businesswire.com

Sensus Healthcare Secures New $15 Million Credit Facility

June 5, 2026 | tipranks.com

Sensus Healthcare Shareholders Back Board, Pay, and Auditor

June 2, 2026 | tipranks.com

How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes

May 20, 2026 | finance.yahoo.com

Sensus Healthcare Balances Weak Quarter With Growth Catalysts

May 20, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NMTC, NYXH, DXR, and SRTS Company Descriptions

Daxor NASDAQ:DXR

$10.27 0.00 (0.00%)

As of 09/4/2026 03:59 PM Eastern

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

NeuroOne Medical Technologies NASDAQ:NMTC

$1.62 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Nyxoah NASDAQ:NYXH

$1.62 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Sensus Healthcare NASDAQ:SRTS

$3.19 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NMTC, NYXH, DXR, and SRTS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NMTC, NYXH, DXR, and SRTS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NMTC, NYXH, DXR, and SRTS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NMTC, NYXH, DXR, and SRTS Company Descriptions

Daxor NASDAQ:DXR

NeuroOne Medical Technologies NASDAQ:NMTC

Nyxoah NASDAQ:NYXH

Sensus Healthcare NASDAQ:SRTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NMTC, NYXH, DXR, and SRTS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NMTC, NYXH, DXR, and SRTS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NMTC, NYXH, DXR, and SRTS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NMTC, NYXH, DXR, and SRTS Company Descriptions

Daxor NASDAQ:DXR

NeuroOne Medical Technologies NASDAQ:NMTC

Nyxoah NASDAQ:NYXH

Sensus Healthcare NASDAQ:SRTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools